Actively Recruiting
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Led by Forte Biosciences, Inc. · Updated on 2025-11-20
32
Participants Needed
6
Research Sites
71 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of FB102 in patients with severe to very severe alopecia areata (AA).
CONDITIONS
Official Title
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males aged 18 to 60 years and females aged 18 to 75 years at Screening
- Clinical diagnosis of severe to very severe alopecia areata with at least 50% scalp hair loss confirmed by SALT score and central photo review
- No other cause of hair loss apart from alopecia areata
- Study center will confirm if participant meets all inclusion criteria
You will not qualify if you...
- Presence of other types of alopecia such as diffuse AA, traction, scarring alopecia, telogen effluvium, trichotillomania, chemotherapy-induced hair loss, or androgenetic alopecia
- Other scalp diseases affecting alopecia areata assessment such as psoriasis, dermatitis, or tinea capitis
- Active systemic diseases causing hair loss including lupus, thyroiditis, systemic sclerosis, lichen planus, or syphilis
- Study center will confirm if participant meets all exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
St Leonards
Saint Leonards, New South Wales (nsw), Australia, 2065
Not Yet Recruiting
2
Coorparoo
Coorparoo, Queensland, Australia, 4151
Actively Recruiting
3
South Yarra
South Yarra, Victoria, Australia, 3141
Not Yet Recruiting
4
Auckland
Auckland, Auckland, New Zealand, 0632
Not Yet Recruiting
5
Christchurch
Christchurch, Canterbury, New Zealand, 8013
Not Yet Recruiting
6
Palmerston North
Palmerston North, Palmerston North Central, New Zealand, 4414
Not Yet Recruiting
Research Team
S
Support Officer
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here